Stockscreener 앱 받기
3.03
0.66%
-0.02
시간 외 거래:
3.06
0.03
+0.99%
Maravai Lifesciences Holdings Inc 주식(MRVI)의 최신 뉴스
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences Holdings, Inc. (MRVI) reports Q4 loss, beats revenue estimates - MSN
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
[Form 4] MARAVAI LIFESCIENCES HOLDINGS, INC. Insider Trading Activity - Stock Titan
Maravai (MRVI) General Counsel has 39,976 shares withheld for taxes - Stock Titan
Insider Sell: What are Maravai LifeSciences Holdings Incs earnings expectationsShort Setup & Capital Protection Trade Alerts - baoquankhu1.vn
Maravai LifeSciences (NASDAQ:MRVI) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
2026-03-15 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation | NDAQ:MRVI | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Analysts - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire
Maravai LifeSciences Holdings Q1 2025 Earnings Preview - MSN
2026-03-08 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | NDAQ:MRVI | Press Release - Stockhouse
How rising interest rates impact Maravai LifeSciences Holdings Inc. stockEntry Point & Precise Trade Entry Recommendations - Naître et grandir
How does Maravai LifeSciences Holdings Inc score in quality rankings2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
Targets Report: What are Maravai LifeSciences Holdings Incs earnings expectations2025 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat
Royce & Associates LP Has $5.06 Million Stock Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
First Eagle Investment Management LLC Makes New Investment in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
MRVI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MRVI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Maravai Lifesciences Charts Early Turnaround in 2025 - TipRanks
Maravai LifeSciences (NASDAQ:MRVI) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Maravai LifeSciences Holdings (MRVI) Stock Analysis: Assessing a Potential 14% Upside in the Biotechnology Sector - DirectorsTalk Interviews
Maravai LifeSciences Holdings (MRVI) Posts US$130.8m TTM Loss Challenging Margin Recovery Narratives - simplywall.st
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap UpStill a Buy? - MarketBeat
Is Maravai LifeSciences Holdings Inc.’s ROE strong enoughMarket Growth Report & Fast Exit and Entry Trade Guides - mfd.ru
Maravai Q4 2025 slides: return to positive EBITDA on cost cuts - Investing.com Nigeria
Maravai LifeSciences Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Maravai LifeSciences Holdings Inc (MRVI) Q4 2025 Earnings Call Highlights: Surpassing Revenue ... By GuruFocus - Investing.com Canada
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results - BioSpace
Maravai LifeSciences Q4 Earnings Call Highlights - MarketBeat
Maravai LifeSciences Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:MRVI) 2026-02-26 - Seeking Alpha
Maravai LifeSciences Holdings Inc (MRVI) Q4 2025 Earnings Call H - GuruFocus
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Maravai Q4 2025 slides: return to positive EBITDA on cost cuts By Investing.com - Investing.com South Africa
Earnings call transcript: Maravai Lifesciences Q4 2025 beats EPS forecast, stock jumps 4.5% - Investing.com Canada
MRVI: 2025 saw revenue beat, margin recovery, and strong 2026 growth and profitability guidance - TradingView
Maravai LifeSciences Holdings Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Maravai LifeSciences (NASDAQ:MRVI) Issues Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Maravai LifeSciences Holdings, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
MRVI Projects FY26 Adjusted EBITDA Between $18M and $20M - GuruFocus
Maravai LifeSciences (MRVI) Surpasses Revenue Expectations in Q4 - GuruFocus
Maravai LifeSciences (NASDAQ: MRVI) posts 2025 loss but targets 2026 EBITDA rebound - Stock Titan
Maravai LifeSciences Q4 2025 Earnings Call Transcript - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Analysts Offer Insights on Healthcare Companies: Indivior (INDV), Arcellx Inc (ACLX) and Maravai Lifesciences Holdings (MRVI) - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
What are Maravai LifeSciences Holdings Inc.’s growth levers2025 Geopolitical Influence & Weekly High Return Stock Opportunities - mfd.ru
Maravai LifeSciences Holdings, Inc. $MRVI Shares Bought by Monaco Asset Management SAM - MarketBeat
Value Recap: What is the PEG ratio of Maravai LifeSciences Holdings IncEarnings Overview Report & Daily Entry Point Alerts - baoquankhu1.vn
Maravai LifeSciences Holdings (MRVI) Investor Outlook: Navigating a 27.55% Upside Amidst Challenging Metrics - DirectorsTalk Interviews
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Stock Traders Purchase High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (MRVI) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
12 West Capital (NASDAQ: MRVI) discloses 6.2% beneficial stake in Maravai - Stock Titan
Is There An Opportunity With Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 34% Undervaluation? - Yahoo Finance
1.20%
0.06%
자본화:
|
볼륨(24시간):